Cancer Vaccines

·
· Current Topics in Microbiology and Immunology 第 405 冊 · Springer
電子書
210
頁數
評分和評論未經驗證 瞭解詳情

關於這本電子書

This volume focuses on the laboratory and clinical experience with targeting viral onco-antigens, while also reviewing the approaches to targeting self-cancer antigens in cancers of non-viral origin, where self-tolerance has been a challenge. It emphasizes the importance of selecting the right vaccine platform to induce a successful immune response against cancer antigens. In addition, the volume discusses the advances made with genetic vaccines, including recent advances with DNA vaccines and the rapid transition of mRNA vaccines from the laboratory to bedside. The new avenues opening up for cancer immunotherapy underline the importance of combinational approaches using cancer vaccines with costimulatory antibodies, which may dramatically improve cancer treatment.
This book is intended for all translational researchers and clinicians who aspire to develop novel vaccination approaches for cancer patients with unmet clinical needs.

關於作者

Dr. Natalia Savelyeva is a lecturer in cancer immunology in Southhampton Dr. Christian Ottensmeier is a professor of experimental medicine in Southhampton

為這本電子書評分

請分享你的寶貴意見。

閱讀資訊

智能手機和平板電腦
請安裝 Android 版iPad/iPhone 版「Google Play 圖書」應用程式。這個應用程式會自動與你的帳戶保持同步,讓你隨時隨地上網或離線閱讀。
手提電腦和電腦
你可以使用電腦的網絡瀏覽器聆聽在 Google Play 上購買的有聲書。
電子書閱讀器及其他裝置
如要在 Kobo 等電子墨水裝置上閱覽書籍,你需要下載檔案並傳輸到你的裝置。請按照說明中心的詳細指示,將檔案傳輸到支援的電子書閱讀器。